Key facts
- This page summarizes Jonathan D. Root's Form 3 filing for CARLSMED, INC..
- 0 reported transactions and 7 derivative rows are listed below.
- Accepted by SEC: 22 Jul 2025, 17:31.
Jonathan D. Root - 22 Jul 2025 Form 3 Insider Report for CARLSMED, INC.
- Reporting relationship
- Director
- Issuer ticker
- CARL on Nasdaq
- Reported as of
- 22 Jul 2025
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 22 Jul 2025, 17:31:13 UTC
- Prior SEC filing
- 08 Jul 2025
- Next SEC filing
- 07 Oct 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Leonard Greenstein, as attorney-in-fact for Jonathan Root
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jonathan D. Root filed Form 3 for CARLSMED, INC. on 22 Jul 2025.
Change
- Previous filing in this sequence was filed on 08 Jul 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001225480
Primary reporting owner
ROOT JONATHAN D
- Relationship
- Director
- Address
- C/O CARLSMED, INC., 1800 ASTON AVE., SUITE 100, CARLSBAD
- Signature
- /s/ Leonard Greenstein, as attorney-in-fact for Jonathan Root
- Signature date
- 22 Jul 2025
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CARL
holding
Derivative
Series A Preferred Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 22 Jul 2025
- Ownership
- See Footnotes
- Underlying class
- Common Stock
- Underlying amount
- 2,948,794
- Exercise price
- Footnotes
- F1, F4, F5
CARL
holding
Derivative
Series B Preferred Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 22 Jul 2025
- Ownership
- See Footnotes
- Underlying class
- Common Stock
- Underlying amount
- 825,135
- Exercise price
- Footnotes
- F1, F4, F5
CARL
holding
Derivative
Series C Preferred Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 22 Jul 2025
- Ownership
- See Footnotes
- Underlying class
- Common Stock
- Underlying amount
- 531,877
- Exercise price
- Footnotes
- F1, F4, F5
CARL
holding
Derivative
Series A Preferred Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 22 Jul 2025
- Ownership
- See Footnotes
- Underlying class
- Common Stock
- Underlying amount
- 149,655
- Exercise price
- Footnotes
- F2, F4, F5
CARL
holding
Derivative
Series B Preferred Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 22 Jul 2025
- Ownership
- See Footnotes
- Underlying class
- Common Stock
- Underlying amount
- 41,876
- Exercise price
- Footnotes
- F2, F4, F5
CARL
holding
Derivative
Series C Preferred Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 22 Jul 2025
- Ownership
- See Footnotes
- Underlying class
- Common Stock
- Underlying amount
- 26,993
- Exercise price
- Footnotes
- F2, F4, F5
CARL
holding
Derivative
Series C Preferred Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 22 Jul 2025
- Ownership
- See Footnotes
- Underlying class
- Common Stock
- Underlying amount
- 1,117,743
- Exercise price
- Footnotes
- F3, F4, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Stock held by U.S. Venture Partners XII, L.P. ("USVP XII").
Footnote F2
Stock held by U.S. Venture Partners XII-A, L.P. ("USVP XII-A").
Footnote F3
Stock held by U.S. Venture Partners Select Fund I, L.P. ("USVP SFI"), on its own behalf and as nominee for U.S. Venture Partners Select Fund I-A, L.P. ("USVP SFI-A").
Footnote F4
Presidio Management Group XII, L.L.C ("PMG XII") is the general partner of USVP XII and USVP XII-A. Presidio Management Group Select Fund I, L.L.C ("PMG SFI," and, together with USVP XII, USVP XII-A, USVP SFI, USVP SFI-A, and PMG XII, "USVP") is the general partner of USVP SFI and USVP SFI-A. The Reporting Person is a managing member of PMG XII and PMG SFI and may be deemed to share voting and dispositive power over the stock held by USVP. The Reporting Person disclaims beneficial ownership of such stock, except to the extent of any pecuniary interest therein.
Footnote F5
These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the "Reverse Split"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis and have no expiration date.